To raise awareness about myeloma and highlight the most important issues for European patients, as well as generate data and discuss solutions, Myeloma Patients Europe (MPE) holds European Myeloma Day on 27 September.
This year MPE is highlighting the role of clinical trials in advancing myeloma treatments and improving patients Quality of Life (QoL).
LEARN more about key facts on clinical trial access, SHARE your patient experience and drive CHANGE by exploring the MPE Navigator.
LEARN more about the challenges of clinical trial access in Central Eastern Europe (CEE) and the importance of Quality of Life (QoL) data for myeloma patients across Europe.
Read the reports “Assessment of Quality of Life data in myeloma clinical trials between 2011 and 2021” and “Addressing access barriers to myeloma clinical trials in Central and Eastern Europe (CEE)” here.
SHARE your experience!
Help us spread the word by sharing our graphics or posting the quote cards on your social media profiles. Click here to download our graphic resources and editable files.
Help drive CHANGE in clinical trial access!